期刊文献+

骶髂关节和脊柱MRI对炎性背痛患者非放射学轴性脊柱关节炎的诊断价值

下载PDF
导出
摘要 目的探讨骶髂关节和脊柱MRI对炎性背痛患者非放射学轴性脊柱关节炎(non radiological axial spondyloarthritis,NR-axSpA)的诊断价值。方法选择2020年1月~2021年12月在该院就诊的疑似NR-axSpA患者81例,采用MRI检测骶髂关节[骨髓水肿(bone marrow edema,BME)、深部病变、脂肪化生、软骨下侵蚀、回填]和背侧脊柱MRI(BME、棘突间滑囊炎、后关节炎和脂肪化生)征象,绘制MRI征象预测NR-axSpA的受试者工作曲线(receiver operating curve,ROC),计算灵敏度、特异性、符合度,计算诊断的阳性似然比(PLR)=灵敏度/(1-特异性)。结果最终43例确诊为NR-axSpA,诊断率53.09%。骶髂关节MRI结果显示:NR-axSpA组和非NR-axSpA组患者在BME数量≥1、BME数量≥3、关节后方BME、软骨下侵蚀数量≥1、软骨下侵蚀数量≥3、关节后方软骨下侵蚀、脂肪化生数量≥1、脂肪化生数量≥3、回填信号等方面的差异均有统计学意义(P<0.05)。背侧脊柱MRI显示:NR-axSpA组和非NR-axSpA组患者在BME数量≥3、脂肪化生数量≥3方面的差异存在统计学意义(P<0.05)。骶髂关节预测NR-axSpAPLR的有价值征象(PLR≥4)包括关节后BME高信号、软骨下侵蚀数量≥1、关节前软骨下侵蚀、脂肪化生数量≥3,软骨下侵蚀数量≥3。背侧脊柱MRI预测NR-axSpA有价值征象(PLR≥4)为BME数量≥3。骶髂关节BME≥3和软骨下侵蚀数量≥3联合预测NR-axSpA的灵敏度为0.3256,特异性为0.8947,符合度为0.5926,PLR为3.0930;PLR结果为NC及PLR≥4联合预测NR-axSpA的灵敏度为0.8140,特异性为0.9737,符合度为0.8889,PLR为30.9302。结论在NR-axSpA评估中不仅要关注BME的重要性,还要关注T1加权像结构损伤(脂肪化生、侵蚀、回填等)及背侧脊柱MRI的补充诊断价值。
出处 《颈腰痛杂志》 2024年第1期164-168,共5页 The Journal of Cervicodynia and Lumbodynia
  • 相关文献

参考文献5

二级参考文献40

  • 1王庆文,曾庆馀,肖征宇,陈肃标,刘源,吴名耀.脊柱关节病患者骶髂关节细针活检的病理表现及其临床意义[J].中华内科杂志,2004,43(11):832-836. 被引量:41
  • 2Rudwaleit M, van der Heijde D, Landewe R, et al. The de- velopment of Assessment of Spondylo arthritis International So- ciety classification criteria for axial spondyloarthritis (part II ): validation and final selection[J]. Ann Rheum Dis, 2009, 68: 777-783. DOI: 10.1136/ard.2009.108233.
  • 3Rudwaleit M, van der Heijde D, Landewe R, et al. The Assess- ment of Spondylo arthritis International Society classification cri- teria for peripheral spondyloarthritis and for spondyloarthritis in general[J]. Ann Rheum Dis, 2011, 70: 25-31. DOI: 10.1136/ard. 2010.133645.
  • 4Sieper J, van der Heijde. Nonradiographic axial spondyloarthri- tis: new definition of an old disease? [J]. Arthritis Rheumatol, 2013, 65: 543-551. DOI: 10.1002/art.37803.
  • 5Ward MM, Deodhar A, Elie A, et al. American College of Rheumatology/Spondylitis Association of America/Spondyloarthri- tis Research and Treatment Network 2015 recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis[J]. Arthritis Rheumatol, 2016, 68: 282-298. DOI: 10.1002/art.39298.
  • 6Braun J, van den Berg R, Baraliakos X, et al. 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis[J]. Ann Rheum Dis, 2011, 70: 896-904. DOI: 10.1136/ard.2011.151027.
  • 7Smolen JS, Braun J, Dougados M, et al. Treating spondy- loarthritis, including ankylosing spondylitis and psoriatic arthri- tis, to target: recommendations of an international task force[J]. Ann Rheum Dis, 2014, 73: 6-16. DOI: 10.1136/annrheumdis- 2013-203419.
  • 8Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables[J]. J Clin Epidemiol, 2011, 64: 383-394. DOI: 10.1016/j. jclinepi.2010.04.026.
  • 9Poddubnyy D, Sieper J. Similarities and differences between nonradiographic and radiographic axial spondyloarthritis: a clin- ical, epidemiological and therapeutic assessment[J]. Curr Opin Rheumatol, 2014, 6: 212-215. DOI: 10.1097/BOR.000000000 0000071.
  • 10Kihz U, Baraliakos X, Karakostas P, et al. Do patients with non-radiographic axial spondylarthritis differ from patients with ankylosing spondylitis?[J]. Arthritis Care Res, 2012, 64: 1415- 22. DOI: 10.1002/acr.21688.

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部